Malignant Solid Tumor Clinical Trials in Beijing, Beijing Municipality
5 recruitingBeijing, Beijing Municipality, China
Showing 1–5 of 5 trials
Recruiting
Phase 2
Phase II Study of JS212/JS213 as Monotherapy and in Combination in Patients With Advanced Malignant Solid Tumors
Advanced malignant solid tumors
Shanghai Junshi Bioscience Co., Ltd.410 enrolled1 locationNCT07480733
Recruiting
Phase 1
A Phase I Study to Evaluate the Safety, Tolerability, and PK of HLX43 in Advanced/Metastatic Solid Tumors
Advanced/Metastatic Malignant Solid Tumors
Shanghai Henlius Biotech367 enrolled10 locationsNCT06115642
Recruiting
Phase 1
A Study of CSCJC3456 in Patients With Advanced Malignant Tumors
Advanced malignant solid tumors
Changshan ConjuChem BioPharmaceutical Research and Development (Hebei) Co., Ltd.102 enrolled2 locationsNCT06717750
Recruiting
Phase 1
A Clinical Study of 9MW2821 in Advanced Malignant Solid Tumors
Advanced malignant solid tumors
Mabwell (Shanghai) Bioscience Co., Ltd.40 enrolled2 locationsNCT05773937
Recruiting
Early Phase 1
Evaluate the Safety and Tolerability of JCXH-212 Monotherapy and Combined With Toripalimab in the Treatment of Malignant Solid Tumors
Malignant Solid Tumors
Peking University Cancer Hospital & Institute24 enrolled1 locationNCT05579275